Palvella Therapeutics (PVLA) Revenue Growth (5y) (2019 - 2024)
Palvella Therapeutics (PVLA) Revenue Growth (5y) (2019 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Palvella Therapeutics |
1.42 Bn |
1.16 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2024 |
-63.82% |
| Sep 30, 2023 |
13.28% |
| Jun 30, 2023 |
11.40% |
| Mar 31, 2023 |
-14.15% |
| Sep 30, 2022 |
-41.99% |
| Jun 30, 2022 |
13.36% |
| Mar 31, 2022 |
52.25% |
| Dec 31, 2021 |
12.74% |
| Sep 30, 2021 |
28.80% |
| Jun 30, 2021 |
18.81% |
| Mar 31, 2021 |
59.82% |
| Dec 31, 2020 |
45.11% |
| Sep 30, 2020 |
47.95% |
| Jun 30, 2020 |
134.01% |
| Mar 31, 2020 |
127.50% |
| Sep 30, 2019 |
281.50% |
| Jun 30, 2019 |
50.17% |
